GlaxoSmithKline settles health care fraud case for $3 billion
WASHINGTON (Legal Newsline) -- GlaxoSmithKline will plead guilty and pay $3 billion in criminal and civil penalties for fraud, according to the Justice Department.
The fraud resulted from GSK's unlawful promotion of certain prescription drugs, failure to report certain safety data and for alleged false price reporting practices. The settlement is the largest payment for health care fraud in U.S. history. GSK is one of the world's leading research-based pharmaceutical and health care companies.
Read the full story on Legal Newsline ...